<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="article-21944" content-type="chapter" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">statpearls</book-id>
    <book-title-group>
      <book-title>StatPearls</book-title>
    </book-title-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <month>01</month>
      <year>2024</year>
    </pub-date>
    <publisher>
      <publisher-name>StatPearls Publishing</publisher-name>
      <publisher-loc>Treasure Island (FL)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 2024, StatPearls Publishing LLC</copyright-statement>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">
        <license-p>
This book is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)
(<ext-link xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/" ext-link-type="uri">
http://creativecommons.org/licenses/by-nc-nd/4.0/
</ext-link>), which permits others to distribute the work, provided that the article is not altered or used commercially. You are not required to obtain permission to distribute this article, provided that you credit the author and journal.
</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="disclaimer">
      <p>The intent of StatPearls review books and articles is to identify knowledge deficits and assist you in the learning process. Review books and articles are not intended to be a source of the knowledge base of medicine. The authors and editors do not warrant the information is complete or accurate. The reader is encouraged to verify content and questions in several references. All drug indications and dosages should be verified before administration.</p>
      <p>The authors and editors would like to extend special thanks to Erin Hughes and Gerson Rubio for their editorial support.</p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <title-group>
        <title>Fraction of Inspired Oxygen</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Fuentes</surname>
            <given-names>Stepfany</given-names>
          </name>
          <aff>Campbell University-Cape Fear Valley</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Chowdhury</surname>
            <given-names>Yuvraj S.</given-names>
          </name>
          <aff>State University of New York - Downstate</aff>
        </contrib>
      </contrib-group>
      <author-notes>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Stepfany Fuentes declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Yuvraj Chowdhury declares no relevant financial relationships with ineligible companies.</p>
        </fn>
      </author-notes>
      <pub-history>
        <date date-type="updated">
          <day>29</day>
          <month>11</month>
          <year>2022</year>
        </date>
      </pub-history>
    </book-part-meta>
    <body>
      <sec id="article-21944.s1" sec-type="Definition/Introduction">
        <title>Definition/Introduction</title>
        <p content-type="pubmed-excerpt">The fraction of inspired oxygen (FiO2) is the concentration of oxygen in the gas mixture. The gas mixture at room air has a fraction of inspired oxygen of 21%, meaning that the concentration of oxygen at room air is 21%. The percentage of oxygen at different altitudes remains the same, meaning the FiO2 of air in the atmosphere remains 21%, irrespective of the altitude of an individual.<xref ref-type="bibr" rid="article-21944.r1">[1]</xref></p>
      </sec>
      <sec id="article-21944.s2" sec-type="Issues of Concern">
        <title>Issues of Concern</title>
        <p>To understand FiO2, it is crucial to understand a few other terms:</p>
        <list list-type="bullet">
          <list-item>
            <p>Hypoxemia: Is defined as a decrease in the partial pressure of oxygen in the blood.<xref ref-type="bibr" rid="article-21944.r2">[2]</xref></p>
          </list-item>
          <list-item>
            <p>PaO2:&#x000a0;Partial pressure of oxygen of arterial as measured by an arterial blood gas sample.<xref ref-type="bibr" rid="article-21944.r3">[3]</xref></p>
          </list-item>
          <list-item>
            <p>PAO2:&#x000a0;Partial pressure of oxygen of the alveoli, a calculated&#x000a0;value.<xref ref-type="bibr" rid="article-21944.r3">[3]</xref></p>
          </list-item>
        </list>
      </sec>
      <sec id="article-21944.s3" sec-type="Clinical Significance">
        <title>Clinical Significance</title>
        <p>The fraction of inspired oxygen, FiO2, is an estimation of the oxygen content a person inhales and is thus involved in gas exchange at the alveolar level. Understanding oxygen delivery and interpreting FiO2 values are imperative for the proper treatment of patients with hypoxemia. Hypoxemia, especially in the critically ill, has been shown to increase all-cause mortality.<xref ref-type="bibr" rid="article-21944.r4">[4]</xref>&#x000a0;When oxygen consumption and supply are mismatched, cell damage and death occur.<xref ref-type="bibr" rid="article-21944.r5">[5]</xref>&#x000a0;The key is recognizing the cause and, thus, the appropriate route of treatment.&#x000a0;</p>
        <p>Inhaled atmospheric gas is 21% oxygen. The amount of oxygen inhaled, i.e., FiO2 is not equivalent to the oxygen which participates in gas exchange at the alveolar level. Several factors need merit consideration and are summarized by the alveolar gas equation. The equation takes into account the barometric pressure (P), water vapor pressure (P), and gas exchange ratio (Rq). The partial pressure of alveolar oxygen (PAo2)= [{P(ATM) - P(H2O}FiO2] &#x02013; [PaCO2/Rq]. What can be assumed from this direct relationship is that as FiO2 increases, so should Pao2. An alternative surrogate for alveolar oxygen saturation is SpO2, oxygen saturation obtained with pulse oximetry.</p>
        <p>FiO2 can be adjusted based on Spo2; however, when to start supplemental oxygen is widely contested.&#x000a0;In patients with COPD, there have been suggestions to begin supplemental oxygen when the SpO2 drops below 88%. In patients without pulmonary disease but with myocardial infarction or stroke, the minimum recommended SpO2 is 93%.<xref ref-type="bibr" rid="article-21944.r5">[5]</xref>&#x000a0;Studies show there is increased mortality with high levels of SpO2 above 96%.<xref ref-type="bibr" rid="article-21944.r5">[5]</xref>&#x000a0;The severity of hypoxemia will determine the best mode of supplemental oxygen.</p>
        <p>Oxygen delivery devices such as a nasal cannula, venturi mask, and high-flow nasal cannula can deliver varying FiO2. A patient breathing ambient air is inhaling a FiO2 of 21%. Oxygen delivery devices determine the flow rate and FiO2 based on predicted equipment algorithms. The conventional prediction model states that for every liter of oxygen supplied, the FiO2 increases by 4%. Therefore, a nasal cannula set at a 1 L/min flow rate can increase FiO2 to 24%, 2 L/min to 28%, 3 L/min to 32%, 4 L/min to 36%, 5 L/min to 40%, and 6 L/min to 44%.</p>
        <p>Recent studies have shown, however, that at low-flow oxygen (particularly below 5 L/min), this conventional prediction is not accurate. The patient receives a mixture of pure oxygen supplied by a nasal cannula and room air, which at low-flow rates does not equal 4% per liter. In vitro testing with a mechanical test lung demonstrated that inspiratory flow has a major impact on FiO2 delivery at low-flow rates.<xref ref-type="bibr" rid="article-21944.r6">[6]</xref>&#x000a0;A new prediction formula was proposed by the authors during this study accounting for the effect of inspiratory flow in patients breathing spontaneously on low-flow supplemental oxygen. The proposed prediction model states that the fraction of oxygen delivered is 0.21 + (1/(4 x minute ventilation)) x L/min of O2.<xref ref-type="bibr" rid="article-21944.r6">[6]</xref>&#x000a0;This equation applies when the inspiratory time to total inspiratory-expiratory time ratio was 0.33. The fraction of oxygen delivered formula changes to 0.21 + (1/(2.5 x minute ventilation)) x L/min of O2 when the inspiratory time to total inspiratory expiratory time ratio changes to 0.5. The authors reported that this prediction formula had greater good accuracy for predicting the fraction of oxygen delivered at low flow rates via supplemental oxygenation through a heat-and-moisture exchanger in patients who breathe spontaneously.<xref ref-type="bibr" rid="article-21944.r6">[6]</xref></p>
        <p>A venturi mask can provide a 1&#x000a0;to 15 L/min flow rate, and FiO2 is titrated based on the valve. The valves are categorized by color, with the blue valve providing the lowest flow rate and FiO2, 2&#x000a0;to 4 L/min, and FiO2 24%, respectively. The green valve allows the maximum 12&#x000a0;to 15 L/min flow rate with 60% FiO2. A nonrebreather can provide a 10&#x000a0;to 15 L/min flow rate; FiO2 varies from 60 to 90%.<xref ref-type="bibr" rid="article-21944.r7">[7]</xref>&#x000a0;Lastly, there is a high-flow nasal cannula. This method can provide flow rates up to 60 L/min and FiO2 of 21%&#x000a0;to 100%, irrespective of the flow rate.<xref ref-type="bibr" rid="article-21944.r3">[3]</xref></p>
        <p>As mentioned above, oxygen devices can provide much higher flow rates than a normal patient's inspiratory flow. However, the reported FiO2 that is delivered is not always accurate.&#x000a0;Based on previous studies, the understanding is that the delivered flow rates are lower than the predicted FiO2.<xref ref-type="bibr" rid="article-21944.r8">[8]</xref>&#x000a0;Studies have shown FiO2 provided via nasal cannula increased by 2.5% per 1 L/min.<xref ref-type="bibr" rid="article-21944.r8">[8]</xref>&#x000a0;HFNC, with a setting of &#x0003e;30 L/min flow rate, delivered the most accurate FiO2. Another factor that can alter FiO2 is humidity. Dry air, aside from being uncomfortable for patients, has the potential to increase airway resistance by inducing acute damage and inflammation. Dry air can also cause increased water loss and decreased mucociliary clearance. Interestingly even having a patient's mouth open can increase the delivered Fio2.<xref ref-type="bibr" rid="article-21944.r9">[9]</xref></p>
        <p>In the setting of critically ill patients, FiO2 is routinely used to assess the lungs' capacity for gas exchange., using the PaO2/FiO2 (P/F) ratio, where PaO2 represents the partial pressure of oxygen. The most notable use of this metric is in the Berlin criteria, which categorizes ARDS as mild (201&#x000a0;to 300 mmHg), moderate (101&#x000a0;to 200 mmHg), and severe (less than 100 mmHg). While cardiac output, hemoglobin concentration, and barometric pressure can affect the P/F ratio, it remains a reasonable assessment of pulmonary function.<xref ref-type="bibr" rid="article-21944.r10">[10]</xref></p>
        <p>Lastly, there has been much debate as to the use of high FiO2 during surgery. Previously it was suggested perioperative oxygen would decrease the risk of surgical site infections, rate of atelectasis, myocardial infarction, and ICU admission. The World Health Organization, in addition to several meta-analyses, has shown no benefit in perioperative hyperoxia.<xref ref-type="bibr" rid="article-21944.r11">[11]</xref></p>
      </sec>
      <sec id="article-21944.s4">
        <title>Review Questions</title>
        <list list-type="bullet">
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=21944&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=21944">Access free multiple choice questions on this topic.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/articlelibrary/commentarticle/21944/?utm_source=pubmed&#x00026;utm_campaign=comments&#x00026;utm_content=21944">Comment on this article.</ext-link>
</p>
          </list-item>
        </list>
      </sec>
    </body>
    <back>
      <ref-list id="article-21944.s5">
        <title>References</title>
        <ref id="article-21944.r1">
          <label>1</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Peacock</surname>
                <given-names>AJ</given-names>
              </name>
            </person-group>
            <article-title>ABC of oxygen: oxygen at high altitude.</article-title>
            <source>BMJ</source>
            <year>1998</year>
            <month>Oct</month>
            <day>17</day>
            <volume>317</volume>
            <issue>7165</issue>
            <fpage>1063</fpage>
            <page-range>1063-6</page-range>
            <pub-id pub-id-type="pmid">9774298</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21944.r2">
          <label>2</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Sarkar</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Niranjan</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Banyal</surname>
                <given-names>PK</given-names>
              </name>
            </person-group>
            <article-title>Mechanisms of hypoxemia.</article-title>
            <source>Lung India</source>
            <year>2017</year>
            <season>Jan-Feb</season>
            <volume>34</volume>
            <issue>1</issue>
            <fpage>47</fpage>
            <page-range>47-60</page-range>
            <pub-id pub-id-type="pmid">28144061</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21944.r3">
          <label>3</label>
          <element-citation publication-type="book">
            <person-group person-group-type="author">
              <name>
                <surname>Sharma</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Danckers</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Sanghavi</surname>
                <given-names>DK</given-names>
              </name>
              <name>
                <surname>Chakraborty</surname>
                <given-names>RK</given-names>
              </name>
            </person-group>
            <chapter-title>High-Flow Nasal Cannula</chapter-title>
            <source>StatPearls [Internet]</source>
            <publisher-name>StatPearls Publishing</publisher-name>
            <publisher-loc>Treasure Island (FL)</publisher-loc>
            <year>2023</year>
            <month>4</month>
            <day>6</day>
            <pub-id pub-id-type="pmid">30252327</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21944.r4">
          <label>4</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Allardet-Servent</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Forel</surname>
                <given-names>JM</given-names>
              </name>
              <name>
                <surname>Roch</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Guervilly</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Chiche</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Castanier</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Embriaco</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Gainnier</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Papazian</surname>
                <given-names>L</given-names>
              </name>
            </person-group>
            <article-title>FIO2 and acute respiratory distress syndrome definition during lung protective ventilation.</article-title>
            <source>Crit Care Med</source>
            <year>2009</year>
            <month>Jan</month>
            <volume>37</volume>
            <issue>1</issue>
            <fpage>202</fpage>
            <page-range>202-7, e4-6</page-range>
            <pub-id pub-id-type="pmid">19050631</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21944.r5">
          <label>5</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Allardet-Servent</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Sicard</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Metz</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Chiche</surname>
                <given-names>L</given-names>
              </name>
            </person-group>
            <article-title>Benefits and risks of oxygen therapy during acute medical illness: Just a matter of dose!</article-title>
            <source>Rev Med Interne</source>
            <year>2019</year>
            <month>Oct</month>
            <volume>40</volume>
            <issue>10</issue>
            <fpage>670</fpage>
            <page-range>670-676</page-range>
            <pub-id pub-id-type="pmid">31054779</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21944.r6">
          <label>6</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Duprez</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Mashayekhi</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Cuvelier</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Legrand</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Reychler</surname>
                <given-names>G</given-names>
              </name>
            </person-group>
            <article-title>A New Formula for Predicting the Fraction of Delivered Oxygen During Low-Flow Oxygen Therapy.</article-title>
            <source>Respir Care</source>
            <year>2018</year>
            <month>Dec</month>
            <volume>63</volume>
            <issue>12</issue>
            <fpage>1528</fpage>
            <page-range>1528-1534</page-range>
            <pub-id pub-id-type="pmid">30467224</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21944.r7">
          <label>7</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Drake</surname>
                <given-names>MG</given-names>
              </name>
            </person-group>
            <article-title>High-Flow Nasal Cannula Oxygen in Adults: An Evidence-based Assessment.</article-title>
            <source>Ann Am Thorac Soc</source>
            <year>2018</year>
            <month>Feb</month>
            <volume>15</volume>
            <issue>2</issue>
            <fpage>145</fpage>
            <page-range>145-155</page-range>
            <pub-id pub-id-type="pmid">29144160</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21944.r8">
          <label>8</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Markovitz</surname>
                <given-names>GH</given-names>
              </name>
              <name>
                <surname>Colthurst</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Storer</surname>
                <given-names>TW</given-names>
              </name>
              <name>
                <surname>Cooper</surname>
                <given-names>CB</given-names>
              </name>
            </person-group>
            <article-title>Effective inspired oxygen concentration measured via transtracheal and oral gas analysis.</article-title>
            <source>Respir Care</source>
            <year>2010</year>
            <month>Apr</month>
            <volume>55</volume>
            <issue>4</issue>
            <fpage>453</fpage>
            <page-range>453-9</page-range>
            <pub-id pub-id-type="pmid">20406513</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21944.r9">
          <label>9</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Nishimura</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>High-Flow Nasal Cannula Oxygen Therapy in Adults: Physiological Benefits, Indication, Clinical Benefits, and Adverse Effects.</article-title>
            <source>Respir Care</source>
            <year>2016</year>
            <month>Apr</month>
            <volume>61</volume>
            <issue>4</issue>
            <fpage>529</fpage>
            <page-range>529-41</page-range>
            <pub-id pub-id-type="pmid">27016353</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21944.r10">
          <label>10</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Feiner</surname>
                <given-names>JR</given-names>
              </name>
              <name>
                <surname>Weiskopf</surname>
                <given-names>RB</given-names>
              </name>
            </person-group>
            <article-title>Evaluating Pulmonary Function: An Assessment of PaO2/FIO2.</article-title>
            <source>Crit Care Med</source>
            <year>2017</year>
            <month>Jan</month>
            <volume>45</volume>
            <issue>1</issue>
            <fpage>e40</fpage>
            <page-range>e40-e48</page-range>
            <pub-id pub-id-type="pmid">27618274</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21944.r11">
          <label>11</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Meyhoff</surname>
                <given-names>CS</given-names>
              </name>
              <name>
                <surname>Wetterslev</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Jorgensen</surname>
                <given-names>LN</given-names>
              </name>
              <name>
                <surname>Henneberg</surname>
                <given-names>SW</given-names>
              </name>
              <name>
                <surname>H&#x000f8;gdall</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Lundvall</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Svendsen</surname>
                <given-names>PE</given-names>
              </name>
              <name>
                <surname>Mollerup</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Lunn</surname>
                <given-names>TH</given-names>
              </name>
              <name>
                <surname>Simonsen</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Martinsen</surname>
                <given-names>KR</given-names>
              </name>
              <name>
                <surname>Pulawska</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Bundgaard</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Bugge</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Hansen</surname>
                <given-names>EG</given-names>
              </name>
              <name>
                <surname>Riber</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Gocht-Jensen</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Walker</surname>
                <given-names>LR</given-names>
              </name>
              <name>
                <surname>Bendtsen</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Johansson</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Skovgaard</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Helt&#x000f8;</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Poukinski</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Korshin</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Walli</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Bulut</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Carlsson</surname>
                <given-names>PS</given-names>
              </name>
              <name>
                <surname>Rodt</surname>
                <given-names>SA</given-names>
              </name>
              <name>
                <surname>Lundbech</surname>
                <given-names>LB</given-names>
              </name>
              <name>
                <surname>Rask</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Buch</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Perdawid</surname>
                <given-names>SK</given-names>
              </name>
              <name>
                <surname>Reza</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Jensen</surname>
                <given-names>KV</given-names>
              </name>
              <name>
                <surname>Carlsen</surname>
                <given-names>CG</given-names>
              </name>
              <name>
                <surname>Jensen</surname>
                <given-names>FS</given-names>
              </name>
              <name>
                <surname>Rasmussen</surname>
                <given-names>LS</given-names>
              </name>
              <collab>PROXI Trial Group</collab>
            </person-group>
            <article-title>Effect of high perioperative oxygen fraction on surgical site infection and pulmonary complications after abdominal surgery: the PROXI randomized clinical trial.</article-title>
            <source>JAMA</source>
            <year>2009</year>
            <month>Oct</month>
            <day>14</day>
            <volume>302</volume>
            <issue>14</issue>
            <fpage>1543</fpage>
            <page-range>1543-50</page-range>
            <pub-id pub-id-type="pmid">19826023</pub-id>
          </element-citation>
        </ref>
      </ref-list>
    </back>
  </book-part>
</book-part-wrapper>
